That’s the environment where Venkatesh Kanneganti, a senior IEEE member, and a seasoned Quality Assurance and validation ...

Public trust in scientific integrity is eroded by the politicisation of institutions under Donald Trump's US presidency. The implications extend far beyond American borders, striking at the core of ...

A Ph.D. student in biomolecular engineering at the University of California, Santa Cruz, has built a software program ...

Mustang Bio makes the NASDAQ top percentage gainers list on FDA news, currently trading at $3.56. up $2.37, gaining 199% on volume of over 152 Million shares as of this report. The stock has a day's ...

Dr. Singh took a pragmatic view of the booming biotech startup sector, which has grown from 50 startups in 2014 to over 11,000 today.

The National Security Commission on Emerging Biotechnology (NSCEB) delivered its major report and action plan to Congress in early April with a blunt message: the world is entering a new age driven by ...

Biotech is guessing how Vinay Prasad might change the FDA. His research, writing offer clues. In published research, CBER’s new chief has campaigned for drugmakers to generate more convincing clinical ...

The 10 most innovative biotech companies of 2025 are leveraging AI to find new drugs, match patients with the best treatments, and even support biodiversity research.

‘Paper mills’ are contaminating the world’s scholarly output with fake papers that hinder research. Lifesaving biomedical fields are especially hard hit.

Those famously understated words introduced a research paper written by James Watson and Francis Crick that appeared in Nature in April 1953.

The Flanders Institute of Biotechnology urges a coalition of EU member states to ensure the success of the 2025 Biotech Act.